Answers are grounded in this paper and cite their sources.
Methicillin-resistant Staphylococcus aureus (MRSA) causes high morbidity and mortality throughout the world. 3’-Demethoxy-6-O-demethylisoguaiacin (LT8) is a 2,7′-cyclolignan isolated and structurally characterized from Larrea tridentata leaves. In this study, LT8 was incorporated into calcium alginate nanoparticles through a nanoemulsion method. Nanoparticles without LT8, LT8-loaded nanoparticles (NPLT8), and LT8 were analysed by ATR-FTIR to detect spectral changes associated with nanoparticle formation. Particle size (PS) and zeta potential (ζP) of NPLT8 formulations were measured by dynamic light scattering (DLS) and zeta potential analysis. Nanoscale imaging was obtained for three formulations. Results showed that formulation with 500 µg/mL of LT8 (NPLT8-500) had an average particle size of 545.8 ± 115.2 nm and a ζP value of −16.7 ± 4.47 mV. This formulation exhibited the highest encapsulation efficiency (EE), which was determined by HPLC. A kinetic antibacterial assay was conducted at 24, 48, and 72 h to evaluate LT8 release from the NPLT8-500 compared with LT8 and tetracycline against MRSA. NPLT8-500 did not show antibacterial activity (MIC > 200 µg/mL) compared with LT8 (MIC = 5 µg/mL) and tetracycline (MIC = 0.3125 µg/mL) at 24 h. However, after 72 h incubation time, NPLT8-500, LT8, and tetracycline exhibited MIC values of 1.5625, 5, and 1.25 µg/mL, respectively. Further, target prediction and molecular docking identified MenA as a potential LT8 target. In silico ADMET analysis indicated favourable drug-likeness and oral absorption, but moderate solubility and rapid clearance. These findings support the development of nanoparticle formulations to improve systemic exposure and enable controlled release of LT8.
No takes yet. Share an insight, caveat, or question.
Barajas-Saracho et al. (2026) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: